Matthew Catley
Treating Asthma with Monoclonal Antibody Based Drugs: Past Experience and Future Prospects
September 22 by Pharmaceuticals & Biotechnology EditorAsthma Insights with Matthew Catley, UCB
April 29 by Matthew CatleyMatthew Catley, Head of Respiratory Pharmacology, UCB, provides some insights into asthma and COPD. Please give some background about your company. What is your role, and what does it entail? U...